AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 11 min read$ILMN

Meister Keith A. sold $3.2M of ILMN (indirect holdings)

Meister Keith A. sold 19,832 indirectly-held shares of ILLUMINA, INC. (ILMN) at $163.57 ($3.24M total) on 2026-05-29.

Original reporting
SEC EDGAR · Meister Keith A.
Published Jun 1, 2026, 10:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ILMN
Neutral
medium confidence
Mentioned
$ILMN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ILMNNeutralLow
01

Why it matters

The disclosure may slightly influence sentiment, but it does not introduce new guidance, contracts, litigation, or performance data.

02

Market read

Traders may monitor whether additional insider transactions follow, but the filing alone is unlikely to drive a sustained repricing.

03

What to watch

The article notes no pre-arranged 10b5-1 plan, which can increase interpretive weight, but the disclosure still lacks any stated reason for the sale or linkage to new information.

Relevance 6/10Novelty 6/10Timing: Filed June 1; sale dated May 29 (post-close disclosure window).

Background

This is an SEC Form 4 insider transaction: a director sold Illumina shares via open-market sale.

Company-level read

Ticker impact

$ILMNNeutralMedium confidence
Context

Illumina director Keith Meister sold 19,832 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely limited near-term impact; any effect should be small versus broader fundamentals.

Evidence & confidence

The filing is an ownership-change disclosure without accompanying operational/financial news; also the plan status (10b5-1 not used) can matter, but the article contains only the sale details.

Market effects

Sector

Minimal; single-company insider sale typically does not reset sector expectations.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Director sales can be routine for diversification/tax and do not necessarily reflect a bearish view on Illumina’s prospects.

Key entities

  • issuer
    Illumina, Inc.

    Subject of the Form 4 insider sale disclosure.

  • insider
    Keith A. Meister

    Director who sold 19,832 shares on May 29, 2026.

Read at source← All news

Related articles

AUG 4
$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Illumina (ILMN) reported Q2 2026 revenue of $1.16B, up 9.5% YoY, and non-GAAP EPS of $1.31. Clinical consumables and NovaSeq X placements drove results. Gross margin was 68.2%. Full-year 2026 guidance was raised to $4.60B-$4.64B revenue and $5.30-$5.40 EPS. Cash was $1.17B vs $1.99B debt.

fool.com6 min
JUL 31
$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Conor McNamara Chief Executive Officer - Jacob Thaysen Chief Financial Officer - Ankur Dhingra TAKEAWAYS Total Revenue -- $1.16 billion, representing a 9.5% increase year over year driven by clinical market demand and the NovaSeq X expansion. Rest of World Organic Revenue -- Increased 8.1% year over year, exceeding the high end of management's previous guidance.

fool.com6 min
JUL 30
$ILMNMedAI 8/10

Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full

Genomics company Illumina (NASDAQ: ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.62 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.31 per share was 6.8% above analysts’ consensus estimates. Is now the time to buy Illumina? Find out by accessing our full research report, it’s free.

financialcontent.com6 min
JUL 30
$ILMNHigh

ILLUMINA, INC. (ILMN): Results of Operations and Financial Condition

ILLUMINA, INC. (ILMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226earningsrelease.htm EX-99.1 Document Investors: Conor McNamara +1.858.291.6421 ir@illumina.com Media: Christine Douglass pr@illumina.com Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 San Diego, July 30, 2026 /PRNewswire/ -- Illumina, Inc.

SEC EDGAR 8-K3 min